HopeStage
Back to all studies
UnknownNCT05894902

Open-Label Dose-Ranging Study of Oral SM-001 in Healthy Adults

Medication studyAges 25–65United StatesPTSD
The study in practice

Understand this study

Who could participate?

This study is for healthy volunteers. Listed age limits: 25 years to 65 years. Other eligibility criteria apply.

Listed locations
SeattleSee all locations and recruitment
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateEstimated: October 1, 2023
Recruitment status
Unknown
Enrollment listed in the registry
12
Sponsor
Advanced Integrative Medical Science Institute
Sponsor type
Research institute
Study type
Drug
Intervention type
Drug
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Locations
United States
Age range
From 25 Years to 65 Years
Official registry ID
NCT05894902
Official title
Show the full official title

Open-Label Dose-Ranging Study of Oral SM-001 in Healthy Adults

Recruitment & locations

Status unknown

Seattle

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Advanced Integrative Medical Science Institute, a research institute.

Does this study involve medication?

Yes. The study involves medication, including SM-001.

Who can participate?

This study is for healthy volunteers. Listed age limits: 25 years to 65 years. Other eligibility criteria apply.

Want to explore more studies?

Explore studies